What development phase is Quimethazin in?

Quimethazin is FDA-approved (marketed).

What is the generic name of Quimethazin?

QUINETHAZONE is the generic (nonproprietary) name of Quimethazin.

Last reviewed 2026-04-20 · How we verify

Quimethazin (QUINETHAZONE)

FDA-approved approved Small molecule Quality 20/100

At a glance

Generic name	QUINETHAZONE
Drug class	quinethazone
Target	Solute carrier family 12 member 3
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved
First approval	1963

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Quimethazin CI brief — competitive landscape report
Quimethazin updates RSS · CI watch RSS